Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 65,57 € (-17,91 %). Medianen er 65,57 € (-17,91 %).
| Køb |
6 |
| Behold |
2 |
| Sælg |
0 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Exponent CEO Catherine Corrigan sells 1,737 shares under 10b5-1 plan
Chief Executive Catherine Corrigan sold 1,737 Exponent shares at an average price of $62.78 on July 15 via a 10b5-1 trading plan following an exercise of 2,379 options at a $29.05 strike. The sale was partly to cover the option exercise and related taxes; Corrigan still holds 115,771 shares worth about $7.2 million post-transaction. The transaction is described as routine and not a red flag, but Exponent shares have lagged the S&P 500, falling 11.7% over the past year through July 17 including dividends. » Mere på finance.yahoo.com
Exponent raises 2025 dividend to $1.20 and pays out $61.54 million
At the annual general meeting on 04.06.2026, Exponent approved a 2025 dividend of $1.20, up 7.14% year-on-year, with total payout of $61.54 million (+5.72%). The dividend yield for 2025 is 1.71% based on a closing price of $59.48 on the AGM day. Over five years the stock lost 32.42%; including dividends the real return is -25.82%. FactSet expects a 2026 dividend of $1.24 (expected yield 2.08%); Exponent has a market capitalization of $2.813 billion, P/E 33.91, revenue of $582.01 million and EPS of $2.07 for 2025. » Mere på finanzen.net
Exponent unveils new leadership and board reshuffle
Exponent names John Pye president, who will report to CEO Catherine Corrigan, and appoints Eric Anderson as chief financial officer effective May 1, 2026. Richard Schlenker resigns as CFO but remains executive vice president and has been nominated to the board of directors. Paul Johnston will leave the board at the annual general meeting on June 4, 2026; Karen Richardson will then become board chair. The company reports a strong balance sheet with more cash than liabilities, a market capitalization of $3.28 billion and 13 consecutive years of dividend growth, underscoring stability during the leadership transition; the stock is trading near its 52-week low. » Mere på de.investing.com
Exponent boosts revenue in third quarter by 8% and beats earnings expectations
Exponent reported Q3 2025 revenue up 8% to $147.1 million and EPS up 10% to $0.55, beating the consensus of $0.51. Net income, EBITDA and billable hours also increased, while cumulative performance through Oct. 3 showed more moderate growth and slight declines in profitability. Management reaffirmed the full-year guidance, expects low- to mid-single-digit revenue growth in Q4 and approved an additional $100 million share repurchase program. » Mere på de.investing.com
Exponent faces short thesis from Prosper Stars & Stripes citing AI threat and rich valuation
Prosper Stars & Stripes highlighted Exponent, Inc. (EXPO) as a meaningful short, arguing AI could reduce the need for expert consulting and pressure a billable-hours business model. The fund noted EXPO trades at a premium (over 20x EV/EBITDA) versus peers and flagged downside risk despite recent share declines and modest revenue growth. » Mere på finance.yahoo.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | oktober 2026 | YoY |
|---|---|---|
| Omsætning | 154,3 mio. | 23,14 % |
| Bruttofortjeneste | 43,71 mio. | 39,86 % |
| Nettoresultat | 27,48 mio. | 15,06 % |
| EBITDA | 40,54 mio. | 15,67 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 3,82 mia. € |
Antal aktier | 47,55 mio. |
Højeste/laveste i 52 uger | 82,43 € - 47,28 € |
Udbytteafkast | 1,33 % |
Udbytte TTM | 1,06 € |
Næste udbytte | 0,28 € |
Beta | 0,68 |
P/E (PE Ratio) | 38,01 |
PEG (PEG Ratio) | 2,89 |
K/I (PB Ratio) | 13,78 |
P/S (PS Ratio) | 6,36 |
Virksomhedsprofil
Exponent, Inc. og dets datterselskaber driver globalt virksomhed som konsulentvirksomhed inden for videnskab og ingeniørarbejde. Virksomheden opererer i to segmenter, Engineering and Other Scientific samt Environmental and Health. Segmentet Engineering and Other Scientific leverer ydelser inden for biomekanik, biomedicinsk teknik og videnskaber, bygninger og konstruktioner, anlægsteknik, byggekonsulentvirksomhed, datavidenskab, elektroteknik og datalogi, human factors, materialer og korrosionsteknik, maskinteknik, polymervidenskab og materialekemi, termiske videnskaber samt køretøjsteknik. Segmentet Environmental and Health tilbyder ydelser inden for kemikalieregulering og fødevaresikkerhed, økologiske og biologiske videnskaber, miljø- og jordvidenskaber samt sundhedsvidenskaber. Virksomheden tilbyder cirka 90 tekniske discipliner til at løse presserende og komplicerede udfordringer for interessenter. Den betjener kunder inden for kemi, byggeri, forbrugerprodukter, energi, fødevarer, drikkevarer og ernæring, offentlig sektor, life sciences, forsikring, fremstilling, teknologi, industrielt udstyr, transport og andre dele af økonomien. Virksomheden var tidligere kendt som The Failure Group, Inc. og skiftede navn til Exponent, Inc. i 1998. Exponent, Inc. blev grundlagt i 1967 og har hovedkvarter i Menlo Park, Californien.
| Navn | Exponent |
| CEO | Catherine Ford Corrigan |
| Hjemsted | Menlo Park,
ca USA |
| Websted | |
| Sektor | Industrivirksomheder |
| Branche | Professionelle tjenester |
| Børsnotering | 17.08.1990 |
| Medarbejdere | 1.016 |
Tickersymboler
| Børs | Symbol |
|---|---|
NASDAQ | EXPO |
Frankfurt | EP5.F |
Düsseldorf | EP5.DU |
München | EP5.MU |